The clinical utility of methicillin resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: A diagnostic meta-analysis with antimicrobial stewardship implications
Clinical Infectious Diseases Jan 31, 2018
Parente DM, et al. - Researchers performed this meta-analysis to ascertain the diagnostic value of MRSA nasal screening in MRSA pneumonia. For ruling out MRSA pneumonia, nares screening for MRSA had a high specificity and negative (NPV) predictive value, this was particularly observed in cases of community-acquired pneumonia (CAP)/healthcare-associated pneumonia (HCAP). Based on the NPV, utilization of MRSA nares screening was a valuable tool for AMS to streamline empiric antibiotic therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries